Medicamen Biotech Limited (MEDICAMEQ) — Capital Reinvestment Ratio
Medicamen Biotech Limited (MEDICAMEQ) has a Capital Reinvestment Ratio of 2.09x as of March 2022, meaning it reinvests 2% of its operating cash flow (Rs41.09 Million) in capital expenditures (Rs86.08 Million). Check tangible net worth ratio of Medicamen Biotech Limited to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medicamen Biotech Limited Capital Reinvestment Ratio (2006–2022)
This chart tracks Medicamen Biotech Limited's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Medicamen Biotech Limited.
Annual Capital Reinvestment Ratio for Medicamen Biotech Limited (2006–2022)
Year-by-year Capital Reinvestment Ratio for Medicamen Biotech Limited from 2006 to 2022. See how much free cash does Medicamen Biotech Limited generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.09x | Rs41.09 Million | Rs86.08 Million | ▲ +48.9% |
| 2021 | 1.41x | Rs127.72 Million | Rs179.66 Million | ▼ -52.1% |
| 2020 | 2.94x | Rs128.02 Million | Rs376.11 Million | ▼ -19.4% |
| 2019 | 3.65x | Rs43.01 Million | Rs156.81 Million | ▲ +464.6% |
| 2017 | 0.65x | Rs35.92 Million | Rs23.20 Million | ▲ +494.8% |
| 2016 | 0.11x | Rs62.06 Million | Rs6.74 Million | ▼ -43.1% |
| 2014 | 0.19x | Rs51.39 Million | Rs9.80 Million | ▼ -44.4% |
| 2011 | 0.34x | Rs113.52 Million | Rs38.93 Million | ▼ -89.3% |
| 2010 | 3.20x | Rs11.00 Million | Rs35.20 Million | ▲ +1210.1% |
| 2009 | 0.24x | Rs83.07 Million | Rs20.29 Million | ▼ -82.7% |
| 2008 | 1.41x | Rs22.70 Million | Rs31.97 Million | ▼ -92.8% |
| 2007 | 19.44x | Rs2.59 Million | Rs50.30 Million | ▲ +2501.1% |
| 2006 | 0.75x | Rs26.02 Million | Rs19.45 Million | — |